Aluminum toxicity reduction policies in medicines
2026 · 2nd Quarter (Apr 1 - June 30)
OLD NORTH STRATEGIES, LLC ON BEHALF OF EXELA PHARMA SCIENCES, LLC
Filed by FIRST PRINCIPLES STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Aug 19, 2026
- Income
- $10,000.00
- Expenses
- Not reported
- Registrant
- FIRST PRINCIPLES STRATEGIES, LLC
- Filing UUID
- 6bb8fcdf-3092-4320-9089-53e7a4a2eb4e
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Advanced biotechnology manufacturing policies
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.